5 results match your criteria "adverse cardiac

  • Page 1 of 1

Unplanned Operations and Adverse Events after Surgery for Diaphyseal Fracture of the Clavicle.

Arch Bone Jt Surg 2019 Sep;7(5):402-406

Massachusetts General Hospital, Hand Surgery, Boston, Massachusetts, USA.

Background: We used a database of patients treated at three hospitals to study the primary null hypothesis that there are no factors associated with unplanned reoperations or adverse events after surgical repair for diaphyseal clavicle fracture. Additionally we addressed the following secondary study questions: 1. What is the prevalence of unplanned reoperations or adverse events after surgical repair for diaphyseal clavicle fracture? 2. Read More

View Article and Full-Text PDF
September 2019

[Prognostic Significance of CD45CD117 Cells in Patients with Acute Myeloid Leukemia after Complete Remission].

Zhongguo Shi Yan Xue Ye Xue Za Zhi 2019 Jun;27(3):702-707

Institute of Hematology, Xuzhou Medical University; Department of Hematology of the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, Jiangsu Province,

Objective: To investigate the predictive value of CD45CD117 phenotype-abnormal cells (hereinafter referred to as "abnormal cells") for relapse and prognosis in adult patients with acute myeloid leukemia (AML) within 2 weeks after the first complete remission (CR1).

Methods: The clinical data of patients with newly diagnosed AML (non-acute promyelocytic leukemia) admitted in our department from July 1, 2014 to June 30, 2017 were analyzed retrospectively, and the relationship between clinical features at the initial diagnosis and the abnormal phenotype cells of CD45CD117 within 2 weeks after CR1 with the prognosis were analyzed.

Results: A total of 91 patients with CD45CD117 abnormal cells were detected. Read More

View Article and Full-Text PDF

Efficacy and safety of Levetiracetam as adjunctive treatment in children with focal onset seizures: A systematic review and meta-analysis.

Epilepsy Res 2019 07 3;153:40-48. Epub 2019 Apr 3.

College of Pharmacy, Jinan University, Guangzhou, 510632, China; Institute of Dongguan-Jinan University, Dongguan, 523808, China; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Jinan University, Guangzhou, 510632, China. Electronic address:

Objective: To assess the efficacy and safety of levetiracetam (LEV) as adjunctive treatment in children (0-18 years) with focal-onset seizures (FOS) with a larger dataset.

Methods: A pooled analysis would be performed for prospective clinical trials and a meta-analysis for controlled studies. Retrospectives studies were also summarized using descriptive statistics. Read More

View Article and Full-Text PDF

Onabotulinumtoxin A injections: a safety review of children with clubfoot under 2 years of age at BC Children's Hospital.

Eur J Paediatr Neurol 2014 Mar 10;18(2):171-5. Epub 2013 Nov 10.

Department of Orthopaedics, BC Children's Hospital, Vancouver, BC, Canada.

Background: Pediatric indications for Onabotulinumtoxin A extend beyond treatment of skeletal muscle conditions. Each of the indications for Onabotulinumtoxin A use have adverse events reported in the past. The aim of this study was to review dverse events in children less than 2 years of age who were treated with Onabotulinumtoxin A injections as part of equinus foot deformity, in the setting of clubfoot at British Columbia's Children Hospital. Read More

View Article and Full-Text PDF
  • Page 1 of 1